Clinical Trials Directory

Trials / Conditions / Genital Wart

Genital Wart

18 registered clinical trials studyying Genital Wart5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTo Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Yea
NCT06756269
Shanghai Bovax Biotechnology Co., Ltd.Phase 2
Active Not RecruitingA Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45
NCT06454175
Shanghai Bovax Biotechnology Co., Ltd.Phase 1
Active Not RecruitingA Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese M
NCT06465914
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
TerminatedA Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Ch
NCT05584332
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
CompletedEvaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
NCT05518201
Shanghai Bovax Biotechnology Co., Ltd.Phase 1
UnknownPhase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
NCT05580341
Shanghai Zerun Biotechnology Co.,LtdPhase 3
RecruitingImmune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
NCT05371353
Shanghai Bovax Biotechnology Co., Ltd.
RecruitingImmunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
NCT05027776
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
RecruitingImmunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year
NCT04895020
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
UnknownEducation, Immigration and HPV Vaccination: an Informational Randomized Trial
NCT04905030
Karolinska InstitutetN/A
CompletedEvaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
NCT05372016
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
CompletedGenital Wart and Sexuality in Adolescence
NCT04796090
Ankara City Hospital Bilkent
CompletedEvaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem
NCT04425291
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
RecruitingEvaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female
NCT04422366
Shanghai Bovax Biotechnology Co., Ltd.Phase 3
UnknownSafety and Efficacy of Laser Therapy in Gynaecology
NCT04073082
Juna d.o.o.
CompletedEvaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
NCT03676101
Shanghai Bovax Biotechnology Co., Ltd.Phase 1
UnknownComparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
NCT03153566
Assiut UniversityPhase 3
CompletedLow Dose Cyclophosphamide Treats Genital Warts
NCT00999986
Huazhong University of Science and TechnologyPhase 3